<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>SYPHU-China: Judging Session</title>
        <link>https://video.igem.org/videos/watch/bb7e7099-63cc-4339-8076-bf2b4be37cfd</link>
        <description>Live biotherapeutics for inflammatory bowel disease (IBD) must balance therapeutic persistence with controllable clearance. LBP-Mototype proposes an environment-dependent suicide strategy in Escherichia coli Nissle 1917. Deleting acrB and pspA weakens bile efflux and membrane protection, while inflammation-responsive PspA complementation conditionally restores protection, leaving AcrB absent. Environmental bile stress supplies the damaging agent, avoiding an introduced toxin and aiming to shorten the genetic killing chain. Hydrogen peroxide and tetrathionate are alternative candidate inputs. A reset–targeting–acclimation–clearance cycle allows protective capacity to diverge before stronger stress selects between populations. Protein carry-over could buffer signal fluctuations, while par⁻-associated inheritance variation could produce graded survival and adjust the duration and size of the producing population. Signal reduction offers a candidate manual exit. A separate constitutive module encodes Elafin for local therapeutic delivery. The framework tests whether one conditional-protection pathway can coordinate these functions, linking signal history, viable-cell behaviour, recovery and active extracellular Elafin.</description>
        <lastBuildDate>Sat, 21 Nov 2026 11:01:22 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>SYPHU-China: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/bb7e7099-63cc-4339-8076-bf2b4be37cfd</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=bb7e7099-63cc-4339-8076-bf2b4be37cfd" rel="self" type="application/rss+xml"/>
    </channel>
</rss>